Leukemia Research : Impact Factor & More
eISSN: 1873-5835pISSN: 0145-2126
Share this on:
Key Metrics
CiteScore 
4.9
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.88
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Leukemia Research
Leukemia Research Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | PERGAMON-ELSEVIER SCIENCE LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1977 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Leukemia Research ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Leukemia Research
Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: The role of comorbidities.
- 1 Jul 2026
- Leukemia research
Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase.
- 1 Jul 2026
- Leukemia research
Risk factors and fluid management in tumor lysis syndrome of acute myeloid leukemia: A retrospective study.
- 1 Jul 2026
- Leukemia research
Outcomes and prognostic factors of hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and central nervous system involvement.
- 1 Jun 2026
- Leukemia research
Response-adapted dasatinib de-escalation strategy compared to upfront Low-dose dasatinib: A prospective cohort study.
- 1 Jun 2026
- Leukemia research
Discovery of METTL3 inhibitor C191-0266 as a leukemia therapeutic through targeted modulation of protective autophagy.
- 1 Jun 2026
- Leukemia research
Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: The role of comorbidities.
- 1 Jul 2026
- Leukemia research
Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase.
- 1 Jul 2026
- Leukemia research
Risk factors and fluid management in tumor lysis syndrome of acute myeloid leukemia: A retrospective study.
- 1 Jul 2026
- Leukemia research
Outcomes and prognostic factors of hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and central nervous system involvement.
- 1 Jun 2026
- Leukemia research
Response-adapted dasatinib de-escalation strategy compared to upfront Low-dose dasatinib: A prospective cohort study.
- 1 Jun 2026
- Leukemia research
Discovery of METTL3 inhibitor C191-0266 as a leukemia therapeutic through targeted modulation of protective autophagy.
- 1 Jun 2026
- Leukemia research
FAQs on Leukemia Research
How long has Leukemia Research been actively publishing? 
What is the publishing frequency of Leukemia Research?
How many articles did Leukemia Research publish last year?
What is the eISSN & pISSN for Leukemia Research?
What is Citescore for Leukemia Research?
What is SNIP score for Leukemia Research?
What is the SJR for Leukemia Research?
Who is the publisher of Leukemia Research?
